TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT07142278: DUVAX: A Phase 1 Alzheimer's Vaccine Study Targeting Amyloid-Beta and Tau

Sponsor: Nuravax, Inc. · Phase: PHASE1 · Area: CNS_NEUROLOGY · Target Enrollment: 24 pts

Competing Trials Overlap

3 Active Trials

Excess Burn Exposure

$8,442,880

Rescue Site Savings

+$5,567,024

Unlock Full NCT07142278 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07142278 Rescue Dossier →